Cargando…

Is there hope in improving 5-year overall survival?—review of 5-year overall survival data from KEYNOTE-001

Detalles Bibliográficos
Autores principales:	Akingbemi, Wisdom, Garon, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327376/ https://www.ncbi.nlm.nih.gov/pubmed/32617347 http://dx.doi.org/10.21037/atm-2020-95

Ejemplares similares

Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
por: Garon, Edward B., et al.
Publicado: (2019)

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
por: Hamid, O, et al.
Publicado: (2019)

Nomograms to predict overall survival for patients with endometrial carcinosarcoma
por: Iavazzo, Christos, et al.
Publicado: (2023)

Prediction of 5-year overall survival of tongue cancer based machine learning
por: Li, Liangbo, et al.
Publicado: (2023)

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
por: Han, Kelong, et al.
Publicado: (2015)

Clinicopathological Characteristics and Overall 5-Year Survival of Colorectal Cancer: A Retrospective Study
por: Almuhanna, Rahaf, et al.
Publicado: (2022)

Immunohistochemical subtype and its relationship with 5-year overall survival in breast cancer patients
por: Aldaz-Roldán, Pablo, et al.
Publicado: (2023)

Systematic analysis of overall survival and interactions between tumor mutations and drug treatment
por: Gatto, Francesco, et al.
Publicado: (2016)

Breakthrough 5-year survival with pembrolizumab in Keynote-001 study: horizon shifting in advanced non-small cell lung cancer with immune check point inhibition
por: de Silva, Madhawa, et al.
Publicado: (2020)

Hemisection-hope for last survival
por: Hasija, Mukesh, et al.
Publicado: (2013)

Prognostic nomogram for predicting 5-year overall survival in Chinese patients with high-grade osteosarcoma
por: Yao, Zhihong, et al.
Publicado: (2021)

Nomogram forecasting 3‐, 5‐, and 8‐year overall survival and cancer‐specific survival of gingival squamous cell carcinoma
por: Yan, Lei, et al.
Publicado: (2020)

Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis
por: Li, B, et al.
Publicado: (2016)

Cell cycle progression score as a predictive biomarker for overall survival in patients with adrenocortical carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
por: Monteiro, Andreia Salarini, et al.
Publicado: (2022)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
por: Nie, Ke, et al.
Publicado: (2022)

Comment on: Obesity is Associated with Improved Postoperative Overall Survival, Independent of Skeletal Muscle Mass in Lung Adenocarcinoma by Lee et al.
por: Lee, Duk‐Hee
Publicado: (2022)

Expression of markers of neural stem and progenitor cells in glioblastoma multiforme in relation to tumor recurrence and overall survival
por: Wańkowicz, Paweł, et al.
Publicado: (2020)

Identification of a novel 15‐gene expression signature predicting overall survival of human colorectal cancer
por: Jiang, Chengfei, et al.
Publicado: (2020)

Improvement in Overall Survival from Extremity Soft Tissue Sarcoma over Twenty Years
por: Jacobs, Andrew J., et al.
Publicado: (2015)

Improved 6‐year overall survival in AT/RT – results of the registry study Rhabdoid 2007
por: Bartelheim, Kerstin, et al.
Publicado: (2016)

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016
por: Bogos, Krisztina, et al.
Publicado: (2021)

What Effect Do Pulmonary Micronodules Detected at Presentation in Patients with Osteosarcoma Have on 5-Year Overall Survival?
por: Davison, Reid, et al.
Publicado: (2021)

Author Correction: Prognostic nomogram for predicting 5-year overall survival in Chinese patients with high-grade osteosarcoma
por: Yao, Zhihong, et al.
Publicado: (2021)

Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factors
por: Huszno, Joanna, et al.
Publicado: (2022)

FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma
por: Ferdinandus, Justin, et al.
Publicado: (2022)

Overall 5-year survival rate and disease-free survival after segmentectomy versus lobectomy in patients with non-small cell lung cancer
por: Kadeetham, Khunthorn, et al.
Publicado: (2022)

Progression‐free survival at 3 years is a reliable surrogate for 5‐year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma
por: Yang, Yu‐Xian, et al.
Publicado: (2022)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Prediction of 5–year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods
por: Obrzut, Bogdan, et al.
Publicado: (2017)

An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate
por: Laohawiriyakamol, Supparerk, et al.
Publicado: (2023)

Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis
por: Polak, Tobias B., et al.
Publicado: (2022)

Response to cytotoxic chemotherapy and overall survival in non-small cell lung cancer patients with positive or negative ERCC1 expression
por: Honma, Helen Naemi, et al.
Publicado: (2018)

The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction
por: Wang, Zhengquan, et al.
Publicado: (2020)

DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma
por: Cugliari, Giovanni, et al.
Publicado: (2020)

Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer
por: Guan, Xiuwen, et al.
Publicado: (2023)

Letter to the editor concerning first-line therapy with afatinib – an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations
por: Krawczyk, Paweł, et al.
Publicado: (2015)

Incidence and Overall Survival of Malignant Ameloblastoma
por: Rizzitelli, Alexandra, et al.
Publicado: (2015)

Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress
por: Park, Eun Hwa, et al.
Publicado: (2017)

Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
por: Yan, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e979l6uv3uhs0ivifvejmc0s21